CRBU · CIK 0001619856 · operating
Caribou Biosciences, Inc. (CRBU) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $182 million, Caribou Biosciences, Inc. is a micro-cap company. The stock currently trades at $1.76, down 4.08% today, with a 52-week range of $0.66–$3.54.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.65 | $-1.65 | -19.6% | |
| 2023 | $-1.38 | $-1.38 | +15.9% | |
| 2022 | $-1.64 | $-1.64 | — | |
| 2021 | — | — | — |